Literature DB >> 15007043

Clinicopathological abnormalities and treatment response in 24 dogs seroreactive to Bartonella vinsonii (berkhoffii) antigens.

Edward B Breitschwerdt1, Kasandra R Blann, Martha E Stebbins, Karen R Muñana, Michael G Davidson, Hilary A Jackson, Michael D Willard.   

Abstract

Bartonella vinsonii (B. vinsonii) subspecies berkhoffii is a recently recognized cause of endocarditis, myocarditis, and granulomatous disease in dogs. In an effort to elucidate other potential disease manifestations, the case records of 24 dogs that were seroreactive to B. vinsonii (berkhoffii) antigens were studied retrospectively. Diagnoses included immune-mediated hemolytic anemia, neutrophilic or granulomatous meningoencephalitis, neutrophilic polyarthritis, cutaneous vasculitis, and uveitis. Repeated B. vinsonii (berkhoffii) antibody titers became negative after treatment. This study indicates that a diverse spectrum of disease manifestations and clinicopathological abnormalities can be detected in dogs that are seroreactive to B. vinsonii (berkhoffii) antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007043     DOI: 10.5326/0400092

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  20 in total

1.  Bartonella species as a potential cause of epistaxis in dogs.

Authors:  Edward B Breitschwerdt; Barbara C Hegarty; Ricardo Maggi; Eleanor Hawkins; Page Dyer
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

2.  Infective endocarditis in a dog and the phylogenetic relationship of the associated "Bartonella rochalimae" strain with isolates from dogs, gray foxes, and a human.

Authors:  Jennifer B Henn; Mourad W Gabriel; Rickie W Kasten; Richard N Brown; Jane E Koehler; Kristin A MacDonald; Mark D Kittleson; William P Thomas; Bruno B Chomel
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

3.  Prostatitis, steatitis, and diarrhea in a dog following presumptive flea-borne transmission of Bartonella henselae.

Authors:  Nandhakumar Balakrishnan; Jessica Pritchard; Marna Ericson; Carol Grindem; Kathryn Phillips; Samuel Jennings; Kyle Mathews; Huy Tran; Adam J Birkenheuer; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

Review 4.  Intruders below the radar: molecular pathogenesis of Bartonella spp.

Authors:  Alexander Harms; Christoph Dehio
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

5.  Bartonella vinsonii subsp. berkhoffii endocarditis in a dog from Saskatchewan.

Authors:  Ken R Cockwill; Susan M Taylor; Helene M Philibert; Edward B Breitschwerdt; Ricardo G Maggi
Journal:  Can Vet J       Date:  2007-08       Impact factor: 1.008

6.  Evaluation of blood and bone marrow in selected canine vector-borne diseases.

Authors:  Anna S De Tommasi; Domenico Otranto; Tommaso Furlanello; Silvia Tasca; Cinzia Cantacessi; Edward B Breitschwerdt; Dorothee Stanneck; Filipe Dantas-Torres; Gad Baneth; Gioia Capelli; Donato de Caprariis
Journal:  Parasit Vectors       Date:  2014-12-02       Impact factor: 3.876

7.  Suspected Bartonella osteomyelitis in a dog.

Authors:  Frankie Easley; Lindsay Taylor; Edward B Breitschwerdt
Journal:  Clin Case Rep       Date:  2021-07-21

8.  A confusing case of canine vector-borne disease: clinical signs and progression in a dog co-infected with Ehrlichia canis and Bartonella vinsonii ssp. berkhoffii.

Authors:  Edward B Breitschwerdt; Ricardo G Maggi
Journal:  Parasit Vectors       Date:  2009-03-26       Impact factor: 3.876

9.  Hyperinsulinemic hypoglycemia syndrome in 2 dogs with bartonellosis.

Authors:  E B Breitschwerdt; C Goldkamp; W L Castleman; J M Cullen; P E Mascarelli; L Thalhem; M Schaer
Journal:  J Vet Intern Med       Date:  2014-06-16       Impact factor: 3.333

10.  Bartonella Seroepidemiology in Dogs from North America, 2008-2014.

Authors:  E Lashnits; M Correa; B C Hegarty; A Birkenheuer; E B Breitschwerdt
Journal:  J Vet Intern Med       Date:  2017-12-02       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.